X
Menu

STRATEGIC SERVICES

Vitrian aims to accelerate the speed at which companies and strategic partners can identify, evaluate and acquire/build biomanufacturing capacity. Vitrian uses its deep knowledge of market and industry to serve as a trusted advisor and strategic external partner and address gaps in decision-making across site/building selection, M&A Advisory and NewCo formation, among others.

Strategy &
feasibility

  • Gap assessments
  • Buy-side due diligence
  • Business planning
  • Market + site selection
  • Buy vs. build
  • Academic Medical Center partnership
  • M&A Advisory

CLIENTS AND PARTNERS

CASE STUDIES

  • Vitrian was engaged by a US-based middle market growth fund on supporting an investment in an EU-based aseptic fill-finish contract development and manufacturing organization (CDMO).
  • During due diligence, Vitrian provided feedback on capital budget and plans for the EU CDMO to expand in the US and evaluated ~10 options for follow-on USA acquisition.
  • Vitrian performed a market and cost-based evaluation of existing facilities in the US including asset liquidation value. Vitrian provided overall business plan support and identified gaps in target company’s capital plan.
  • Vitrian sourced a compatible US site with existing products and operating team
  • Vitrian simultaneously finalized a long-term sale leaseback with the partner and represented the partner in negotiating with the CDMO owner of the preferred site.
  • Vitrian contributed acquisition financing through sale-leaseback.

  • Vitrian has partnered with several of the top 15 US academic medical centers (AMCs) with focus in oncology. These AMCs have a stated desire to expand on campus or campus-adjacent advanced therapeutics manufacturing with varying levels of capital and expertise.
  • Vitrian has embedded with their leadership and in-house experts to design, plan, and execute on providing late clinical to commercial manufacturing facilities for internal research work as well as external products. These projects also serve the compatible purpose of attracting non-local biotechs to manufacture their products on campus.
  • Vitrian performed a gap analysis of existing facilities and identified and introduced alternative modalities/companies to support the mission of bringing novel therapies to patients on campus.
  • Vitrian developed project planning for TMC stakeholder approvals, led the design team procurement process, and provided oversight of the design team. Vitrian contributed capitalization through a separate vehicle in partnership with the institution.
STAY IN TOUCH

CONTACT US

For inquiries or more information, contact us at 240.396.1414
or fill out the form below.

This field is for validation purposes and should be left unchanged.
arrow